Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts".
Journal Article (Letter)
Full Text
Duke Authors
- Becker, Richard Clinton
- Lokhnygina, Yuliya Vladimirovna
- Patel, Manesh Raman
- Piccini Sr., Jonathan Paul
Cited Authors
- Piccini, JP; Stevens, SR; Chang, Y; Singer, DE; Lokhnygina, Y; Go, AS; Patel, MR; Mahaffey, KW; Halperin, JL; Breithardt, G; Hankey, GJ; Hacke, W; Becker, RC; Nessel, CC; Fox, KAA; Califf, RM; ROCKET AF Steering Committee and Investigators,
Published Date
- September 10, 2013
Published In
Volume / Issue
- 128 / 11
Start / End Page
- e172 - e173
PubMed ID
- 24019452
Electronic International Standard Serial Number (EISSN)
- 1524-4539
Digital Object Identifier (DOI)
- 10.1161/CIRCULATIONAHA.113.004013
Language
- eng
Conference Location
- United States